# US 2015/0147279 A1 · Preparations of effervescent formulations comprising cephalosporin and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147279 A1
- Document ID: US20150147279A1
- Status: Published application
- Kind: A1
- Application number: 14/605,610
- Filed: 2015-01-26
- Published: 2015-05-28
- Earliest claimed: 2010-01-29
- Inventors: Mahmut BILGIC
- Web page: https://patentgrep.com/patent/US20150147279A1

## CPC

- A61K 9/0007: {Effervescent (A61K9/0065 takes precedence)}
- A61K 31/424: condensed with heterocyclic ring systems, e.g. clavulanic acid
- A61K 31/43: Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula [IMAGE cpc-sch-A61K-0952.gif], e.g. penicillins, penems
- A61K 31/545: Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: [IMAGE cpc-sch-A61K-0953.gif] , e.g. cephalosporins, {cefaclor, or cephalexine}
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 13/00: Drugs for disorders of the urinary system
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/04: Antibacterial agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a process for preparing effervescent dosage forms comprising at least one antibiotic of cephalosporin group. The present invention also relates to effervescent formulations and preparations comprising antibiotics of second generation cephalosporin.

## Claims

### Claim 1

A process for the preparation of a pharmaceutical composition comprising at least one cephalosporin antibiotic in the effervescent form, said method comprising a wet granulation method using a granulation solution comprising 5-25% of water by weight and a pharmaceutically acceptable organic solvent as granulation solvent.

### Claim 2 (depends on 1)

A process according to claim 1, wherein said granulation solution comprises 8-20% of water and a pharmaceutically acceptable organic solvent is used.

### Claim at position 3

3-4. (canceled)

### Claim 5 (depends on 1)

A process according to claim 1, wherein said organic solvent is an alcohol, and said alcohol is selected from the group consisting of methanol, ethanol, prophanol, cethyl alcohol, ethylene glycol, glycerin, and combinations thereof.

### Claim 6 (depends on 5)

A process according to claim 5, wherein ethanol is used as an organic solvent.

### Claim 7 (depends on 6)

A process according to claim 6, wherein said granulation solution comprises a binder in addition to water and ethanol.

### Claim 8 (depends on 6)

A process according to claim 6, wherein the ratio of water to ethanol used in the granulation solution is in the range of 1:1 and 1:15 by weight.

### Claim at position 8

9-10. (canceled)

### Claim 11 (depends on 1)

A process for preparing a pharmaceutical composition according to claim 1, wherein said process comprises the following steps:
a. obtaining a granulation solution by mixing a granulation solvent with 30-60% of total amount of a binder;
b. sieving an effervescent acid and base;
c. sieving a taste regulator;
d. loading the effervescent acid, effervescent base obtained in step b, taste regulator obtained in step c, and 40-70% of the total amount of binder into the fluidized bed dryer and granulating them by the granulation solution prepared in step a;
e. drying and sieving the mixture obtained in step d;
f. mixing at least one cephalosporin antibiotic and one sweetener, and adding the mixture into the granules obtained in step e;
g. adding a flavoring agent and a lubricant to the mixture obtained in step f and mixing; and
h. optionally, compressing the final mixture into tablets in a tablet pressing machine.

### Claim 12 (depends on 11)

A process according to claim 11, wherein 30-60% of the binder is added to the granulation solution, the rest of the binder is added to the mixture that is granulated with this solution in the dryer.

### Claim 13 (depends on 11)

A process according to claim 11, wherein the effervescent couple is sieved by using a sieve that has sieve size in the range of 1-2 mm in the case of any agglomeration.

### Claim 14 (depends on 11)

A process according to claim 11, wherein the granules obtained in the granulation step d are dried at a temperature under 100° C. in the fluidized bed dryer.

### Claim 15 (depends on 11)

A process according to claim 11, wherein the granules obtained in the granulation step d. are dried until the product moisture reaches a value under 2% in the fluidized bed dryer.

### Claim 16 (depends on 1)

A pharmaceutical composition prepared by a process according to claim 1, wherein said composition is prepared in effervescent powder, granule, or tablet form.

### Claim 17

(canceled)

### Claim 18 (depends on 1)

A pharmaceutical composition prepared by a process according to claim 1, wherein the cephalosporin antibiotic is selected from cefaclor, cefuroxime, cefixime, cefprozil, cefdinir, and cefpodoxime.

### Claim 19 (depends on 18)

A pharmaceutical composition according to claim 18, wherein cefprozil and/or cefaclor is used as the cephalosporin antibiotic

### Claim at position 18

20-72. (canceled)
